<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Revolutionary Medical Treatment Shows Promise - NewsPortal</title>
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
            background: linear-gradient(135deg, #0f0f23 0%, #1a1a2e 100%);
            color: #ffffff;
            line-height: 1.8;
            padding: 2rem;
        }
        .container {
            max-width: 800px;
            margin: 0 auto;
            background: rgba(255, 255, 255, 0.05);
            border-radius: 20px;
            padding: 3rem;
            border: 1px solid rgba(255, 255, 255, 0.1);
        }
        .back-link {
            display: inline-block;
            color: #4ecdc4;
            text-decoration: none;
            margin-bottom: 2rem;
            font-weight: 600;
        }
        .back-link:hover { text-decoration: underline; }
        .category {
            background: linear-gradient(45deg, #ff6b6b, #4ecdc4);
            display: inline-block;
            padding: 0.5rem 1rem;
            border-radius: 20px;
            font-size: 0.9rem;
            font-weight: 600;
            margin-bottom: 1rem;
        }
        h1 {
            font-size: 2.5rem;
            margin-bottom: 1rem;
            line-height: 1.2;
        }
        .meta {
            color: #888;
            margin-bottom: 2rem;
            font-size: 0.95rem;
        }
        .content {
            font-size: 1.1rem;
            line-height: 1.8;
        }
        .content p { margin-bottom: 1.5rem; }
    </style>
</head>
<body>
    <div class="container">
        <a href="/" class="back-link">← Back to Home</a>
        <div class="category">Health</div>
        <h1>Revolutionary Medical Treatment Shows Promise</h1>
        <div class="meta">Published 12 hours ago</div>
        <div class="content">
            <p>Clinical trials have unveiled remarkable results for a breakthrough therapy that could fundamentally transform the treatment landscape for rare genetic disorders. The innovative approach combines gene editing technology with personalized medicine techniques, offering hope to patients who previously had limited treatment options.</p>
            
            <p>The therapy, which has been in development for over a decade, demonstrated an 85% success rate in correcting genetic abnormalities in Phase III trials. Patients who received the treatment showed significant improvements in their condition, with many experiencing complete remission of symptoms that had previously been considered untreatable.</p>
            
            <p>Medical researchers emphasize that this breakthrough represents more than just a new treatment option—it validates a entirely new approach to addressing genetic diseases at their molecular foundation. The technique could potentially be adapted to treat a wide range of genetic conditions beyond those included in the current trials.</p>
            
            <p>The treatment protocol involves a one-time administration, eliminating the need for ongoing medication and significantly reducing the long-term burden on patients and healthcare systems. Early economic analyses suggest that despite high initial costs, the therapy could prove cost-effective compared to lifetime management of chronic genetic conditions.</p>
            
            <p>Regulatory approval is expected within the next 18 months, with several health authorities fast-tracking the review process due to the therapy's breakthrough designation. Patient advocacy groups are already working on ensuring equitable access to the treatment once it becomes available.</p>
        </div>
    </div>
</body>
</html>
